Sign in
CompletedNo phase

Protocolised Early De-Resuscitation in Septic Shock (REDUCE)

Key facts

Who runs it
Insel Gruppe AG, University Hospital Bern
Where
Switzerland4 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
170 people enrolled
Started
19 Jul 2021
Ended
7 May 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Fluid management according to the REDUCE Fluid Protocol
  • Standard of care
Record updated
5 May 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients admitted to ICU with the diagnosis of septic shock as defined according to the Sepsis-3 criteria (suspected or confirmed infection AND vasopressor/inotrope ongoing to maintain MAP ≥ 65 mmHg AND Lactate ≥ 2 mmol/l in the last 6 hours

Who cannot take part

  • Patients that are known to be allergic to furosemide or metolazone
  • Age <18 years
  • Septic shock for more than 12 hours at the time of screening
  • Acute burn injury >/= 10% of the body surface area
  • Known pregnancy or lactating women
  • Consent not obtainable due to national legislation
  • Patients on chronic dialysis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Background: Recent studies have questioned the safety of current fluid resuscitation strategies in patients with septic shock as prospective and observational data suggesting that the resulting fluid overload is associated with mortality. Two strategies have evolved to prevent or minimize fluid overload: restrictive fluid administration or active removal of accumulated fluid. While several small trials show benefits with a restrictive fluid administration regimen, active protocolized de-resuscitation was scarcely evaluated. The combination of both strategies yet warrants systematic evaluation.

Read full original descriptionShow less

Aim: This study aims to assess the efficacy and feasibility of an early active de-resuscitation protocol in patients with septic shock. We hypothesize that the application of a structured early de-resuscitation protocol versus standard of care will lead to less fluid overload at day three after ICU admission.

Study Intervention: Patients admitted to the ICU with confirmed or suspected septic shock (Sepsis-3 definition) will be randomized (1:1) to either the intervention or standard of care. In the intervention arm, patients are managed according to the REDUCE fluid management protocol during resuscitation and de-resuscitation.

The 2 groups in the trial

  • Intervention: REDUCE ProtocolTreatment being tested

    Fluid resuscitation and de-resuscitation is based on the REDUCE fluid management protocol.

    Treatment: Fluid management according to the REDUCE Fluid Protocol

  • Standard of CareExisting treatment, for comparison

    Fluid resuscitation and de-resuscitation according to the standard of care

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Protocolised Early De-Resuscitation in Septic Shock (REDUCE) - a Randomised Controlled Multi-centre Feasibility Study
Publications
Record updated
5 May 2026